BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6663710)

  • 21. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
    Chen K
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal cancer.
    McKenna RJ
    West J Med; 1983 Sep; 139(3):362-3. PubMed ID: 6636750
    [No Abstract]   [Full Text] [Related]  

  • 23. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases.
    Erkek B; Ozkan N; Bayar S; Genc V; Ekrem U; Kuzu A; Aribal D
    Hepatogastroenterology; 2007; 54(73):77-80. PubMed ID: 17419235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for colorectal neoplasms. A review and recommendations].
    Kronborg O
    Ugeskr Laeger; 1993 Oct; 155(41):3272-7. PubMed ID: 8256320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of positive Hemoccult test results obtained in a community screening program.
    Heim CR; Rhodes DF; Burger MC; Spickard WA
    J Tenn Med Assoc; 1986 Dec; 79(12):755-8. PubMed ID: 3795935
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of a screening for colorectal carcinoma.--A field-trial in the town Mölln (author's transl)].
    Kruse JU; Jacobi D; Müller-Wieland K
    Z Gastroenterol; 1982 May; 20(5):273-5. PubMed ID: 7102018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of preventive examination for the prognosis of cancer of the large intestine].
    Cappel J; Blum U; Ungeheuer E
    Schweiz Med Wochenschr; 1983 Apr; 113(15):550-2. PubMed ID: 6857210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mass screening for colorectal cancer. The focus in 1995].
    Faivre J; Tazi A; Michiels C
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):71-4. PubMed ID: 7618845
    [No Abstract]   [Full Text] [Related]  

  • 30. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for colorectal cancer with fecal occult blood--an offer to the population?].
    Kronborg O
    Ugeskr Laeger; 1997 Aug; 159(33):4991-2. PubMed ID: 9281216
    [No Abstract]   [Full Text] [Related]  

  • 33. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.
    Erban S; Zapka J; Puleo E; Vickers-Lahti M
    Eff Clin Pract; 2001; 4(1):10-7. PubMed ID: 11234181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas.
    Winawer SJ; Sherlock P
    Cancer; 1982 Dec; 50(11 Suppl):2609-14. PubMed ID: 7139555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer detection in a Community Hospital Screening Program.
    Kurnick JE; Walley LB; Jacob HH; Nakayama L
    JAMA; 1980 May 23-30; 243(20):2056-7. PubMed ID: 7373745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.